Compile Data Set for Download or QSAR
Report error Found 222 Enz. Inhib. hit(s) with all data for entry = 12560
TargetAmine oxidase [copper-containing] 2(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709379({1-[6-((E)-2-Aminomethyl-3-fluoro-allyloxy)-piperi...)
Affinity DataIC50: 4nMAssay Description:An AOC2 enzyme containing cell homogenate is generated by transient transfection of 6×106 HEK293 cells per flask (T75) with 9 μg pCMV-SPORT6-AOC2 (BC...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709366(US12178809, Example 41)
Affinity DataIC50: 5nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709372(US12178809, Example 47)
Affinity DataIC50: 5nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 2(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709382(US12178809, Example 57)
Affinity DataIC50: 6nMAssay Description:An AOC2 enzyme containing cell homogenate is generated by transient transfection of 6×106 HEK293 cells per flask (T75) with 9 μg pCMV-SPORT6-AOC2 (BC...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709342(US12178809, Example 17)
Affinity DataIC50: 8nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM220875(US9302986, 14 | WO2013/163675, Compound 14)
Affinity DataIC50: 8nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709377(US12178809, Example 52)
Affinity DataIC50: 9nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709370(US12178809, Example 45)
Affinity DataIC50: 10nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709371(US12178809, Example 46)
Affinity DataIC50: 10nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709401(US12178809, Example 45)
Affinity DataIC50: 10nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709347(US12178809, Example 22)
Affinity DataIC50: 11nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709390(US12178809, Example 65)
Affinity DataIC50: 11nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709273(US12178809, Example 01)
Affinity DataIC50: 12nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709336(US12178809, Example 11)
Affinity DataIC50: 12nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709363(US12178809, Example 38)
Affinity DataIC50: 13nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709376(US12178809, Example 51)
Affinity DataIC50: 13nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709393(US12178809, Reference Compound A)
Affinity DataIC50: 13nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM385388((E)-3-Fluoro-2-[[2-[(3S)-3-methoxypyrrolidin-1-yl]...)
Affinity DataIC50: 13nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709359(US12178809, Example 34)
Affinity DataIC50: 14nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 2(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709359(US12178809, Example 34)
Affinity DataIC50: 14nMAssay Description:An AOC2 enzyme containing cell homogenate is generated by transient transfection of 6×106 HEK293 cells per flask (T75) with 9 μg pCMV-SPORT6-AOC2 (BC...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709369(US12178809, Example 44)
Affinity DataIC50: 14nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709358(US12178809, Example 33)
Affinity DataIC50: 15nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709362(US12178809, Example 37)
Affinity DataIC50: 15nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709378(US12178809, Example 53)
Affinity DataIC50: 15nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709368(US12178809, Example 43)
Affinity DataIC50: 16nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709357(US12178809, Example 32)
Affinity DataIC50: 17nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709389(US12178809, Example 64)
Affinity DataIC50: 17nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709384(US12178809, Example 59)
Affinity DataIC50: 18nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709387(US12178809, Example 62)
Affinity DataIC50: 18nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709364(US12178809, Example 39)
Affinity DataIC50: 19nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 2(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709378(US12178809, Example 53)
Affinity DataIC50: 19nMAssay Description:An AOC2 enzyme containing cell homogenate is generated by transient transfection of 6×106 HEK293 cells per flask (T75) with 9 μg pCMV-SPORT6-AOC2 (BC...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709388(US12178809, Example 63)
Affinity DataIC50: 19nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709346(US12178809, Example 21)
Affinity DataIC50: 20nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709367(US12178809, Example 42)
Affinity DataIC50: 20nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709375(US12178809, Example 50)
Affinity DataIC50: 20nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709394(US12178809, Example 42)
Affinity DataIC50: 20nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709400(WO2018/027892, Example 2)
Affinity DataIC50: 20nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709356(US12178809, Example 31)
Affinity DataIC50: 21nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709374(US12178809, Example 49)
Affinity DataIC50: 21nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709385(US12178809, Example 60)
Affinity DataIC50: 21nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709391(US12178809, Example 66)
Affinity DataIC50: 23nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709373(US12178809, Example 48)
Affinity DataIC50: 24nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 2(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709375(US12178809, Example 50)
Affinity DataIC50: 24nMAssay Description:An AOC2 enzyme containing cell homogenate is generated by transient transfection of 6×106 HEK293 cells per flask (T75) with 9 μg pCMV-SPORT6-AOC2 (BC...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709328(US12178809, Example 03)
Affinity DataIC50: 25nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709365(US12178809, Example 40)
Affinity DataIC50: 26nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709386(US12178809, Example 61)
Affinity DataIC50: 26nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709399(US12178809, Example 40)
Affinity DataIC50: 26nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709395(US12178809, Reference Compound B)
Affinity DataIC50: 27nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709349(US12178809, Example 24)
Affinity DataIC50: 28nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

TargetAmine oxidase [copper-containing] 3(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM709341(US12178809, Example 16)
Affinity DataIC50: 30nMAssay Description:For the determination of AOC3 activity or compound inhibition potency, the compound inhibitors are dissolved in DMSO and adjusted to the respective a...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/12/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 222 total ) | Next | Last >>
Jump to: